P
Precigenetics provides a label‑free, non‑destructive optical platform that captures chemically resolved, real‑time data from living cells at single‑cell resolution. The system enables drug‑discovery teams to observe target engagement, mechanism of action, and toxicity signals as they occur, accelerating hit identification and reducing late‑stage failures. Revenue is generated through licensing the platform and supplying high‑throughput data services to pharmaceutical and biotech companies.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Accelerates precision medicine by leveraging advanced genomic analysis and machine learning to tailor treatments based on individual genetic profiles. This approach addresses the limitations of one-size-fits-all therapies, enabling more effective and personalized healthcare solutions.